as 12-20-2024 4:00pm EST
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
Founded: | 1998 | Country: | United States |
Employees: | N/A | City: | PHOENIX |
Market Cap: | 4.7M | IPO Year: | N/A |
Target Price: | N/A | AVG Volume (30 days): | 23.2K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -3.80 | EPS Growth: | N/A |
52 Week Low/High: | $1.96 - $10.28 | Next Earning Date: | 11-08-2024 |
Revenue: | $11,000 | Revenue Growth: | -55.28% |
Revenue Growth (this year): | -9.33% | Revenue Growth (next year): | N/A |
CELZ Breaking Stock News: Dive into CELZ Ticker-Specific Updates for Smart Investing
GlobeNewswire
a month ago
Simply Wall St.
a month ago
TipRanks
2 months ago
GlobeNewswire
2 months ago
GlobeNewswire
5 months ago
Simply Wall St.
5 months ago
GlobeNewswire
5 months ago
GlobeNewswire
6 months ago
The information presented on this page, "CELZ Creative Medical Technology Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.